Zinc inhibits NMDA receptor function through both voltagedependent and voltage-independent mechanisms. In this report we have investigated the role that the NR1 subunit plays in voltage-independent Zn 2ϩ inhibition. Our data show that inclusion of exon 5 into the NR1 subunit increases the IC 50 for voltage-independent Zn 2ϩ inhibition from 3-fold to 10-fold when full length exon 22 is also spliced into the mature NR1 transcript and the NMDA receptor complex contains the NR2A or NR2B subunits; exon 5 has little effect on Zn 2ϩ inhibition of receptors that contain NR2C and NR2D. Mutagenesis within exon 5 indicates that the same residues that control proton inhibition, including Lys 211 , also control the effects of exon 5 on Zn 2ϩ inhibition. Amino acid exchanges within the NR1 subunit but outside exon 5 (E181Q, E339Q, E342Q, N616R, N616Q, D669N, D669E, C744A, and C798A) that are known to decrease the pH sensitivity also decrease the Zn 2ϩ sensitivity, and concentrations of spermine that relieve tonic proton inhibition also relieve Zn 2ϩ inhibition. In summary, our results define the subunit composition of Zn 2ϩ -sensitive NMDA receptors and provide evidence for structural convergence of three allosteric regulators of receptor function: protons, polyamines, and Zn 2ϩ .
Zinc inhibits NMDA receptor function through both voltagedependent and voltage-independent mechanisms. In this report we have investigated the role that the NR1 subunit plays in voltage-independent Zn 2ϩ inhibition. Our data show that inclusion of exon 5 into the NR1 subunit increases the IC 50 for voltage-independent Zn 2ϩ inhibition from 3-fold to 10-fold when full length exon 22 is also spliced into the mature NR1 transcript and the NMDA receptor complex contains the NR2A or NR2B subunits; exon 5 has little effect on Zn 2ϩ inhibition of receptors that contain NR2C and NR2D. Mutagenesis within exon 5 indicates that the same residues that control proton inhibition, including Lys 211 , also control the effects of exon 5 on Zn 2ϩ inhibition. Amino acid exchanges within the NR1 subunit but outside exon 5 (E181Q, E339Q, E342Q, N616R, N616Q, D669N, D669E, C744A, and C798A) that are known to decrease the pH sensitivity also decrease the Zn 2ϩ sensitivity, and concentrations of spermine that relieve tonic proton inhibition also relieve Zn 2ϩ inhibition. In summary, our results define the subunit composition of Zn 2ϩ -sensitive NMDA receptors and provide evidence for structural convergence of three allosteric regulators of receptor function: protons, polyamines, and Zn 2ϩ .
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The group II B transition metal ion Z n 2ϩ is widely and variably distributed throughout neurons in the C NS. Z n 2ϩ is released from nerve fibers in a C a 2ϩ -dependent manner and sequestered into neurons via uptake systems with K m values between 10 and 400 M (for review, see Smart et al., 1994) . Although the Zn 2ϩ concentration within the narrow synaptic cleft is dynamic and difficult to quantif y, estimates of the concentration of interstitial synaptically released Z n 2ϩ range from 5 to 500 M (Assaf and Chung, 1984; Howell et al., 1984; Charlton et al., 1985; Aniksztejn et al., 1987) . Of the numerous roles that have been proposed for Zn 2ϩ in the C NS, perhaps the best known are its actions on a host of voltage-and ligand-gated ion channels, including glutamate receptors (Smart et al., 1994; Laube et al., 1995) .
Glutamate receptors can be subdivided on the basis of both structure and pharmacology into three classes: NMDA, kainate, and AM PA receptors. The potential involvement of NMDA receptors in synaptic plasticity and neuronal development (McBain and Mayer, 1994; Scheetz and Constantine-Paton, 1994; Asztely and Gustafsson, 1996) as well as neurological disorders such as epilepsy, ischemic cell death, and neurodegeneration (Choi, 1992; Bradford, 1995; Whetsell, 1996) have f ueled intensive study of all aspects of this receptor, including its sensitivity to extracellular Zn 2ϩ (Peters et al., 1987; Westbrook and Mayer, 1987; Choi and Koh, 1998) . Inhibition of NMDA receptor function by extracellular Zn 2ϩ within the predicted concentration range in the CNS raises the possibility that the modulatory effects of Zn 2ϩ may be an important component of some of the processes and disorders that NMDA receptors are thought to participate in (Peters et al., 1987; Koh et al., 1996) .
In cultured neurons, tens of micromolar Zn 2ϩ can inhibit NMDA receptors through a voltage-dependent channel block that appears to occur within the ion channel pore and may involve residues (e.g., Asn 616 in M2 region of NR1) that are known to influence other NMDA channel-blocking ions such as Mg 2ϩ Christine and Choi, 1990; Legendre and Westbrook, 1990; Mori et al., 1992; Sakurada et al., 1993; Kawajiri and Dingledine, 1993) . Lower concentrations of Zn 2ϩ (Ͻ5 M) can act in a voltage-independent manner to reduce the frequency of channel opening as well as the duration of neuronal NMDA receptor-mediated bursts (Christine and Choi, 1990; Legendre and Westbrook, 1990) .
Five cDNAs have been identified that encode NMDA receptor subunits (NR1, NR2A, NR2B, NR2C, and NR2D; McBain and Mayer, 1994) , and zinc inhibits recombinant receptors comprised of NR1 ϩ NR2 receptors in a dual voltage-dependent and -independent manner that appears to be controlled by the NR2 subunit (Mori et al., 1992; Kawajiri and Dingledine, 1993; Sakurada et al., 1993; Williams, 1996; Chen et al., 1997; Paoletti et al., 1997) . In contrast, very little information exists about the role of alternative splicing of the NR1 subunit RNA on Zn 2ϩ inhibition of heteromeric NMDA receptors (Paoletti et al., 1997) , although the eight possible NR1 splice variants expand structural heterogeneity of the NMDA receptor class considerably. NR1 splicing occurs in a region-and developmental-specific manner (Laurie and Seeburg, 1994; Nash et al., 1997; Paupard et al., 1997) , suggesting it may be used by the C NS to fine tune NMDA receptor responsiveness or influence receptor localization. We have studied the effects of Z n 2ϩ on recombinant NMDA receptors containing different N R1 splice variants to define structural determinants of Z n 2ϩ inhibition. In this report, we describe striking effects of the N-terminal alternative exon 5 on voltageindependent Z n 2ϩ inhibition, some of which are reminiscent of the effects of exon 5 on proton inhibition of NMDA receptors (Zheng et al., 1994; Traynelis et al., 1995) . The similar effects of exon 5 on Zn 2ϩ and proton inhibition lead us to explore whether the modulatory sites for these endogenous ions share similar structural determinants.
Some of these results have appeared in preliminary form (Burgess et al., 1996; Burgess and Traynelis, 1997) .
MATERIALS AND METHODS
NMDA receptor subunit cDNAs. cDNAs encoding the N R1 subunit splice variants (GenBank accession number L08228) as well as N R2A (GenBank numbers AF001423 and CD13211), N R2B (GenBank number U11419), N R2C (GenBank numbers U08259 and M91563), and N R2D (GenBank number L31611) subunits were generously provided by Drs. J. Boulter (University of C alifornia at L os Angeles, L os Angeles, CA), S. Heinemann (Salk Institute, La Jolla, CA), S. Nakanishi (Kyoto University, Kyoto, Japan), and P. Seeburg (Max Planck Institute for Medical Research, Heidelberg, Germany) . N R1(N616R) and N R1(N616Q) were generously provided by Drs. R. Dingledine (Emory University, Atlanta, GA) and K . Moriyoshi (Kyoto University, Kyoto, Japan), respectively. N R1-1a(E181Q), N R1-1a(E339Q), N R1-1a(E342Q), N R1-1b(E363Q), N R1-1a(D669N), and N R1-1a(D669E) were generously provided by K . Williams (University of Pennsylvania, Philadelphia, PA); the wild-type sequence for N R1 subunit for these mutants can be accessed by GenBank number X63255. Other NMDA receptor N R1 subunit mutations (see Fig. 7 ) have been previously described (Sullivan et al., 1994; Traynelis et al., 1995) . All experiments were performed with N R1 subunits that contained exon 21 and exon 22 except those shown in Figures 1 and 2 . N R1 splice variants that contain the two C -terminal alternate exons but lack exon 5 are referred to in the literature as N R1-1a (Hollmann et al., 1993) , N R1 011 (Durand et al., 1992) , and N R1A (Sugihara et al., 1992) . N R1-1b, N R1 111 , and N R1B describe the corresponding cDNA that contains exon 5. We use the nomenclature of Hollmann et al. (1993) , and for simplicity, refer whenever possible to the presence or absence of N R1 exon 5.
E xpression of NMDA receptors in Xenopus ooc ytes. cRNA was synthesized from linearized template cDNA according to manufacturer specifications (Ambion). Quality of synthesized cRNA was assessed by gel electrophoresis, and quantity was estimated by spectroscopy and gel electrophoresis. Stage V and V I oocytes were surgically removed from the ovaries of Xenopus laevis anesthetized with 3-amino-benzoic acid ethylester (1 gm / l). C lusters of ϳ30 oocytes were incubated with 292 U/ml Worthington (Freehold, NJ) type IV collagenase or 1.3 mg /ml collagenase (Life Technologies, Gaithersburg, MD; 17018 -029) for 2 hr in C a 2ϩ -free solution comprised of (in mM) 115 NaC l, 2.5 KC l, and 10 H EPES, pH 7.5, with slow agitation to remove the follicular cell layer. Oocytes were then washed extensively in the same solution supplemented with 1.8 mM CaCl 2 and maintained in Barth's solution comprised of (in mM): 88 NaC l, 1 KC l, 24 NaHC O 3 , 10 H EPES, 0.82 MgSO 4 , 0.33 C a(NO 3 ) 2 , and 0.91 C aC l 2 and supplemented with 100 g /ml gentamycin, 40 g /ml streptomycin, and 50 g /ml penicillin. Oocytes were injected within 24 hr of isolation with 5 ng of N R1 subunit and 5-10 ng of N R2 subunit in a 50 -100 nl volume and incubated in Barth's solution at 18°C for 3-18 d; some oocytes were stored at 4°C after 3-5 d.
Voltage-clamp recordings f rom Xenopus ooc ytes. T wo electrode voltage-clamp recordings were made 3-18 d postinjection. Oocytes were placed in a dual-track recording chamber with a single perf usion line that split to perf use two oocytes, which increased the efficiency of data collection and allowed side-by-side comparisons to be made on oocytes injected with different subunit combinations. Dual recordings were made using Warner model OC725B two-electrode voltage clamps as recommended by the manufacturer. The bath clamps communicated across silver chloride wires placed into each side of the recording chamber, both of which were assumed to be at a reference potential of 0 mV. Oocytes were perf used with a solution comprised of (in mM) 90 NaCl, 1 KCl, 10 H EPES, and 1.0 BaC l 2 , pH 7.3, and held at Ϫ20 to Ϫ40 mV. Z nC l 2 solutions (10 mM) were made fresh every 10 hr and added directly to the recording solution to obtain the desired nominal Z n 2ϩ concentration for all experiments except those with N R2B-and N R2A-expressing receptors. For these receptors, we used tricine to buffer Z n 2ϩ concentrations Ͻ3 M. We used a stability constant (K S ) for Z n-tricine of 10 Ϫ5 M (Vieles et al., 1972; Tripathi et al., 1987; Paoletti et al., 1997) to calculate the nominal free Z n 2ϩ concentration according to: 
where the K A for tricine is 10 Ϫ8.15 . Similar free Z n 2ϩ concentrations were obtained with the use of programs that calculate free ion concentrations (W I NM AXC or BAD; Z heng et al., 1998). H EPES does not contribute to Z n 2ϩ buffering (Benitez et al., 1991) . We estimate a free Zn 2ϩ at pH 7.4 that is ϳ80% of that reported at pH 7.3 by Paoletti et al. (1997) . Our contaminant Z n 2ϩ (Paoletti et al., 1997 ) is ϳ300 nM (Z heng et al., 1998) and arises predominantly from the NaC l. We assume that only free (or f ully hydrated) Z n 2ϩ acts at NMDA receptors, and calculated free Z n 2ϩ concentrations at pH 8.0 using the log stability constants (K Sn ) for Z n(OH) n ϩ2Ϫn of 5.0 (n ϭ 1), 11.1 (n ϭ 2), 13.6 (n ϭ 3), and 14.8 (n ϭ 4; Martell and Smith, 1974) according to:
Secure impalements were usually obtained in solution containing 1 mM CaCl 2 before switching to the BaC l 2 -containing solution. Voltage and current electrodes had resistances of 2-10 M⍀ and were filled with 300 mM KC l. NMDA receptor currents were evoked with 20 M glutamate plus 7-10 M glycine superf used for 1-2 min; washout time was 3-5 min between drug applications. For N R2A-containing receptors, all experiments were performed in 10 M glycine, which is 10ϫ our measured EC 50 value for glycine (1 M; n ϭ 8; data not shown). Solution exchange was computer-controlled through an eight-valve manifold. The flow rate varied minimally between various valves and throughout the experiment. Data anal ysis. Only current responses to glutamate plus glycine that were Ͼ50 nA at pH 7.3 (Ϫ40 mV) and were not potentiated by 1 M Zn 2ϩ (Hollmann et al., 1993) were analyzed to minimize the contribution to our responses of previously described N R1 homomeric receptors, which are probably heteromeric receptors that incorporate Xenopus glutamate receptor subunits (Soloviev et al., 1996) . By this criteria, ϳ6% of recordings were discarded; response amplitude was typically several hundreds of nanoamperes at Ϫ20 mV. Inhibition curves were analyzed as shown in Figure 3A , Zn 2ϩ concentrations were corrected for 0.3 M contaminant Z n 2ϩ for N R2B-containing receptors. For proton inhibition curves, the oocytes were prewashed with the test pH before and after agonist application. E xperimental manipulations were expressed as a percent of pre-event and post-event control responses, and the data were pooled together. Z n 2ϩ inhibition data were fitted (least squares criterion) to the equation:
where n is the Hill slope, IC 50 is the nominal concentration of Z n 2ϩ that produces 50% inhibition, and minimum a residual current response. For all receptors, minimum was fixed to 0 if the fitting algorithm returned a value Ͻ5.6%, our estimated limit of detection for the maximal Z n 2ϩ concentration tested (mean SEM for responses at 100 M Zn 2ϩ was 2.55%). For mutant receptors and N R2C -and N R2D-containing receptors, minimum was fixed to 0. Hill slopes ranged from 0.5 to 1.6; IC 50 values for wild-type N R1/ N R2B,C,D receptors will be slight underestimates of true IC 50 for voltage-independent effects if voltage-dependent inhibition by high concentrations (30 -100 M) of Zn 2ϩ occurs at holding potentials between Ϫ20 and Ϫ40 mV; Hill slopes will be slightly overestimated for the same reason. Throughout the text the IC 50 values that are reported reflect the nominal Z n 2ϩ concentration; effective Z n 2ϩ activity
will be approximately half the nominal concentration given the activity coefficient for Z n 2ϩ of 0.5 (L obo and Quaresma, 1989; Lide, 1997) . Composite proton inhibition curves were constructed using pH 7.6 as a control and fitted using the same equation, except with proton activity substituted for [Z n 2ϩ ] . Proton IC 50 values were determined from the pH-derived activities using an activity coefficient of 0.8 (Lide, 1997) .
Current-voltage ( I-V ) relationships were recorded in response to a 4 sec voltage ramp (Ϫ80 to ϩ40 mV) before, during, and after drug application. The NMDA receptor I-V curve was determined from the difference of current responses in the presence and absence of agonist, and the reversal potential was determined from a fitted polynomial f unction (fifth to ninth order; least squares criterion) or interpolation.
Statistical significance for all tests was set at p Ͻ 0.05, and minimum detectable differences were calculated for a power of 0.7. Error bars in all figures are SEM. Paired and unpaired t tests and ANOVA were performed to evaluate the difference between means; for t tests we used Welch's approximate t statistic when the underlying distributions had different variances.
Voltage-dependent channel block of wild-t ype and mutant NMDA receptors. Because both Z n 2ϩ and polyamines can cause a voltage-dependent block of the NMDA receptor channel, it is important to determine whether this effect complicates any of the experiments we performed. Although we observe a weak voltage-dependent channel block of wildtype N R1-1/ N R2B receptors by 10 M Zn 2ϩ at hyperpolarized potentials (e.g., Ϫ70 mV; n ϭ 9; p Ͻ 0.05), we can detect no voltage-dependent block by extracellular Z n 2ϩ at our typical recording potential, as measured by the ratio of current recorded 30 mV negative to the reversal potential to that recorded 30 mV positive to the reversal potential (I V REVϪ30 /I V REVϩ30 ), determined from current-voltage curves (control I V REVϪ30 /I V REVϩ30 ϭ 1.0 Ϯ 0.02, mean Ϯ SEM; 10 M Zn 2ϩ I V REVϪ30 / I V REVϩ30 ϭ 1.0 Ϯ 0.06; p Ͼ 0.4; n ϭ 9; minimum detectable difference, 15%). We also find no significant effects of exon 5 on channel block induced by addition of 10 M Zn 2ϩ (n ϭ 9 oocytes; data not shown) or 0.5 mM Mg 2ϩ (n ϭ 28 oocytes; data not shown), and no effects of exon 5 on the current-voltage curve recorded when all external Na ϩ was replaced by 61.5 mM Ba 2ϩ (n ϭ 28 oocytes; data not shown). These data suggest the effects of exon 5 on voltage-independent Z n 2ϩ inhibition that we describe here are unlikely to involve ion permeation or block, except perhaps at very high concentrations of Z n 2ϩ . To evaluate the ability of spermine to relieve Z n 2ϩ inhibition (see Fig. 7 ), we have used an N R1 subunit that contains a mutation in the M2 region of the receptor that has previously been shown to relieve voltage-dependent channel block by both Z n 2ϩ and spermine (Mori et al., 1992; Kawajiri and Dingledine, 1993; Sakurada et al., 1993; Kashiwagi et al., 1997) . To confirm that under our recording conditions these M2 mutations relieved voltagedependent Z n 2ϩ inhibition of N R1-1/ N R2B receptors, we constructed current-voltage curves in the presence and absence of extracellular Zn 2ϩ and spermine for wild-type and mutant receptors. We found receptors that contained an arginine residue in place of the M2 Asn 616 in N R1-1a and M2 Asn 637 in N R1-1b (mutant numbering differs because of inclusion of 21 amino acids encoded by exon 5) showed no detectable channel block by Z n 2ϩ at Ϫ30 mV (pooled control I V REVϪ30 /I V REVϩ30 ϭ 1.1 Ϯ 0.04; 30 M Zn 2ϩ I V REVϪ30 /I V REVϩ30 ϭ 1.0 Ϯ 0.1; p Ͼ 0.1; n ϭ 11; minimum detectable difference, 13%) or at Ϫ70 mV (data not shown; n ϭ 23), consistent with the findings of other laboratories (Mori et al., 1992; Kawajiri and Dingledine, 1993; Sakurada et al., 1993) . Similarly, voltage-dependent channel block by 1 mM spermine (see Fig. 5 A, B) was also abolished by the M2 pore mutation in N R1-1a(N616R)/ N R2B and N R1-1b(N637R)/ N R2B receptors (pooled I V REVϪ30 /I V REVϩ30 ϭ 1.2 Ϯ 0.03; n ϭ 11) compared with wild-type N R1-1/ N R2B receptors (I V REVϪ30 /I V REVϩ30 ϭ 0.6 Ϯ 0.05; n ϭ 16; p Ͻ 0.05 by unpaired t test). Similar results were found at more hyperpolarized potentials and with 100 M spermine (n ϭ 27; Kashiwagi et al., 1997) .
RESULTS

Zn
2؉ sensitivity of alternatively spliced NR1 subunits Extracellular Z n 2ϩ is known to inhibit NMDA receptors by both voltage-independent and voltage-dependent mechanisms. Voltage-dependent inhibition appears to involve weak channel block Christine and Choi, 1990; Legendre and Westbrook, 1990) and is controlled by some of the same amino acid residues that control channel block by Mg 2ϩ (Mori et al., 1992; Kawajiri and Dingledine, 1993; Sakurada et al., 1993; see Materials and Methods) . In this study we have examined the ability of NR1 to control voltage-independent inhibition of NMDA receptors by extracellular Zn 2ϩ . To do this, we first evaluated the IC 50 values for Zn 2ϩ inhibition of responses to maximal glutamate and glycine of all NR1 splice variants expressed in combination with the NR2B subunit in Xenopus oocytes. Current responses were recorded from oocytes expressing NMDA receptor subunits that were voltage clamped at depolarized holding potentials (Ϫ20 to Ϫ40 mV) at which voltagedependent channel block by Z n 2ϩ is minimal (see Materials and Methods). by more than fourfold for receptors that had spliced in exon 22 starting at the alternative acceptor site 2647 bp [numbered as in GenBank number X63255; see Hollmann et al. (1993) , their Fig.  1 ]. By contrast, exon 5 had variable effects on the Z n 2ϩ sensitivity of recombinant receptors that had the original stop codon deleted by use of an internal acceptor splice site at 3003 bp within exon 22 [i.e., N R1-3 and N R1-4 by the nomenclature of Hollmann et al. (1993) ]. In two of four batches of oocytes, exon 5 reduced Zn 2ϩ sensitivity of N R1-3/ N R2B and N R1-4/ N R2B receptors by less than twofold when the alternative acceptor splice site within exon 22 was used; in the other batches of oocytes expressing NR1-3/ NR2B and NR1-4/NR2B receptor, exon 5 had much larger effects. This exon 22-linked variability might be related to interactions between proteins endogenous to the oocyte and the PDZ2 site (Kornau et al., 1995) encoded in the new reading frame that results from the deletion of the stop codon (data not shown). Interestingly, the effects of exon 5 on Zn 2ϩ inhibition were largely unaffected by the presence or absence of alternative exon 21 (Fig. 1) .
Inclusion of exon 5 into the NR1 subunit has previously been shown to reduce the proton sensitivity of NR1-1/N R2 receptors (Traynelis et al., 1995) . Because of the similar effects of exon 5 on proton and Zn 2ϩ inhibition of receptors that contain the full length NR1 subunit, we tested whether C-terminal splicing of NR1 controlled the effects of exon 5 on proton inhibition of heteromeric receptors in a parallel manner to Zn 2ϩ inhibition. Figure 1 , D and E, compares the effects of NR1 RNA splicing on proton and Zn 2ϩ inhibition of NR1/NR2B receptors and shows that exon 5 relieves proton inhibition irrespective of C-terminal splicing of NR1 subunit. Similar results for proton inhibition have previously been reported for NR1 splice variants expressed in Xenopus oocytes in the absence of NR2 subunits [Traynelis et al. (1995) , their footnote 13]. Figure 2 A compares more directly the effects of exon 5 on proton and Zn 2ϩ inhibition of various C-terminal splice variants of the NMDA receptor.
The NR2 subunit controls the relief of voltageindependent Zn 2؉ inhibition of exon 5
The NR2 subunit is known to control allosteric regulation of NMDA receptors. For example, both extracellular Mg 2ϩ and polyamines can relieve tonic proton inhibition of NMDA receptors that contain the NR2B subunit, but not other NR2 subunits (Williams et al., 1994; Zhang et al., 1994; Paoletti et al., 1995; Traynelis et al., 1995; Williams, 1995) . To test whether the NR2 subunit influences the ability of exon 5 to decrease voltageindependent Zn 2ϩ inhibition, we constructed Zn 2ϩ inhibition curves for receptors comprised of NR1-1 Ϯ exon 5 and each of the NR2 subunits. Table 1 summarizes these data, which show that exon 5 can reduce the sensitivity to extracellular Zn 2ϩ of receptors that contain NR1-1 and NR2A or NR2B by 4-fold to 10-fold, although the IC 50 for voltage-independent Zn 2ϩ inhibition differs by more than an order of magnitude between NR2A-and NR2B-containing receptors (Paoletti et al., 1997) . By contrast, not only did we find that receptors comprised of NR1-1 plus NR2C (Williams, 1996; Chen et al., 1997) or NR2D subunits were much less sensitive to extracellular Zn 2ϩ , but exon 5 was also less effective in reducing the sensitivity of these receptors to Zn 2ϩ (Table 1) . Because exon 5 exerts similar effects on both the proton and Zn 2ϩ sensitivity of NR1 splice variants (Fig. 2 A) , we also compared the effects of different NR2 subunits on proton and Zn 2ϩ sensitivity of NMDA receptors. As shown in Figure 2 , B and C, we found a correlation between the effects of exon 5 on proton and Zn 2ϩ sensitivity for various heteromeric receptors. This finding, together with similar results from NR1 splice variants, raises the possibility that inhibition by Zn 2ϩ and protons might share common structural or functional determinants.
Although we can detect no channel block by 10 M Zn 2ϩ at approximately Ϫ30 mV (see Materials and Methods), it is still possible that some of the higher Zn 2ϩ concentrations required to inhibit exon 5-containing receptors might complicate our evalua- tion of voltage-independent inhibition by causing some channel block. To test whether exon 5 acts only on voltage-independent Zn 2ϩ inhibition, we examined Z n 2ϩ inhibition of receptors that carried N R1 mutations, N R1-1a(N616R) and N R1-1b(N637R), that have been reported to relieve voltage-dependent Zn 2ϩ inhibition (Mori et al., 1992; Kawajiri and Dingledine, 1993; Sakurada et al., 1993) . Evaluation of the Zn 2ϩ effects of these mutant NR1 subunits showed that although they are somewhat Fitted IC 50 values are shown for the indicated NR1-1/NR2 combinations (assuming complete inhibition for NR2B,C,D); Hill slopes ranged from 0.6 to 1.5. Mean IC 50 values were similar to those determined from the composite curve. All experiments were performed with constructs that contain exon 21 and exon 22. For NR2A the inhibition curves was generated using tricine-buffered Zn 2ϩ (see Materials and Methods). The mutation in the M2 region (N616R or N637R) enhances the effect of exon 5 on the N R1-1/ N R2B and N R1-1/ N R2D IC 50 values, possibly by removing some Zn 2ϩ channel block at high concentrations that probably increased overall Zn 2ϩ inhibition. Voltage-dependent and -independent IC 50 values for NR2A are different enough such that no voltage-dependent block should contaminate inhibition by nanomolar concentrations of Z n 2ϩ (Paoletti et al., 1997) . N R2C has very little voltage-dependent inhibition (Chen et al., 1997) . Thus the effects of N616R mutation were not determined (ND) for these two subunit combinations. All dose -response curves were determined with five or more Zn 2ϩ concentrations; n is the number of oocytes.
less sensitive to voltage-independent inhibition of Z n 2ϩ (see Fig.  4 B) , exon 5 still increases the IC 50 value for Z n 2ϩ inhibition to a similar extent as in wild-type receptors (Table 1) . This result supports the idea that the actions of exon 5 cannot be explained by effects on voltage-dependent block at high concentrations of Zn 2ϩ .
Common structural determinants of proton and Zn 2؉ inhibition
The ability of exon 5 to reduce Z n 2ϩ inhibition suggests that voltage-independent Z n 2ϩ inhibition may share structural features with proton inhibition, further supporting an emerging trend of convergence among allosteric modulatory systems (see Discussion). To evaluate whether a structural argument can be made in support of the idea that Zn 2ϩ and protons act through convergent mechanisms to inhibit NMDA receptors, we tested whether mutations in exon 5 that alter its ability to relieve proton inhibition similarly alter its ability to relieve Zn 2ϩ inhibition. inhibition. Figure 4 A shows that a strong correlation exists be- Figure 4 . Common structural determinants of pH and Z n 2ϩ inhibition. A, There is a strong correlation between the pH and Z n 2ϩ sensitivity of the NMDA receptor across a variety of different N R1 exon 5 mutations. All Z n 2ϩ inhibition curves were determined from heteromeric receptors consisting of N R1-1/ N R2B subunits; IC 50 values describing pH inhibition are data from N R1 subunits expressed in Xenopus oocytes in the absence of NR2 (Traynelis et al., 1995) , except for wild-type NR1-1b, NR1-1b(m207-211), NR1-1b(K214G), and NR1-1b(K211G), which were determined from heteromeric receptors containing NR2B. The amino acids encoded by exon 5 are shown above, with the appropriate symbol denoting the residues that were altered in the triple mutants to G (m192-194, m207-211) or A (m197-205) . B, There is a strong correlation between pH and Zn 2ϩ sensitivity for NR1-1 mutations outside exon 5 that reduce pH sensitivity. All Zn 2ϩ and proton IC 50 values were determined from responses of heteromeric NR1-1/N R2B receptors recorded at five or more different proton or Z n 2ϩ concentrations. The position of residues with marked effects on proton and Zn 2ϩ sensitivity are shown on a linear representation of the NR1 subunit; M1-4 denote membrane-associated regions. For all experiments, the number of oocytes recorded for each proton or Zn 2ϩ inhibition curve ranged between 7 and 40. Broken lines show linear regressions. Figure 5 . Thermodynamic cycle analysis of mutant N R1 subunits. The mutations in exon 5 containing N R1-1b subunits are labeled with the numbering of NR1-1a subunits for clarity. However, the position of these mutations should be increased by 21 residues because of insertion of exon 5. The actual numbering of the mutant pairs is (Ϯ exon 5) E342Q / E363Q, N616R / N637R, C744A /C765A, and C798A /C819A. The coupling coefficient was calculated as indicated assuming our experimental IC 50 values approximate the K D values for protonation. The coupling energies (⌬⌬G) in kilocalories per mole for these various mutations and splice variants are 0.23 for E342/ E363Q Ϯ exon 5, 0.05 for N616/ N637R Ϯ exon 5, Ϫ0.12 for C745/C765A Ϯ exon 5, 0.17 for C798/C819A Ϯ exon 5, and Ϫ0.8 for C745A and C798A. Proton IC 50 values not included in Figures 3 or 4 are (in nM): 1071 N R1-1b(E363Q)/ NR2B, 446 NR1-1b(N637R)/ N R2B, 558 N R1-1b(C765A), 688 N R1-1b(C819A), and 135 N R1-1a(C744A, C798A)/ N R2B. All inhibition curves were constructed for wild-type and mutant N R1-1a and N R1-1b subunits coexpressed with N R2B except for N R1-1b(C765A) and N R1-1b(C819A), which were expressed in Xenopus oocytes in the absence of N R2 (Sullivan et al., 1994). tween the ability of these various exon 5 mutations to relieve proton and Z n 2ϩ inhibition, consistent with the idea that similar structural components within exon 5 influence both proton and Zn 2ϩ inhibition. Does the correlation between N R1-1b mutations within exon 5 that influence Z n 2ϩ and proton inhibition extend to other portions of the receptor? We (Burgess et al., 1996) and others (Kashiwagi et al., 1997) have observed that mutations at Asn 616 in the M2 pore-forming region of the molecule can reduce the sensitivity of the receptor to protons. Figure  4 B shows that this decrease in pH sensitivity is also correlated with a decrease in Z n 2ϩ sensitivity (Table 1 ). In addition, we have also now extended the results of Sullivan et al. (1994) to show that two extracellular cysteine residues (C ys 744 and Cys 798 in NR1-1a) that control redox modulation, proton inhibition, polyamine relief of proton inhibition, and Z n 2ϩ potentiation of NR1-1a expressed in Xenopus oocytes in the absence of NR2 subunits (J. M. Sullivan and S. F. Traynelis, unpublished data) also control Z n 2ϩ inhibition of heteromeric receptors. We also report that several acidic residues that have previously been shown to alter proton inhibition of NMDA receptor function Kashiwagi et al., 1996 ; K . Williams, unpublished observations) cause similar changes in the Zn 2ϩ sensitivity (Fig. 4 B) . The tight correlation between proton and Zn 2ϩ IC 50 values across these various NMDA receptor mutants provide strong evidence that some elements of the mechanism that control proton and Zn 2ϩ inhibition must be similar and that common structural determinants of proton and Zn 2ϩ inhibition are spread throughout the NR1 subunit.
Interactions between exon 5 and NR1 mutations
To evaluate the interactions between exon 5 and NR1 mutations that alter proton and Zn 2ϩ inhibition, we used thermodynamic cycles (Carter et al., 1984) to calculate the coupling energy between the effects of exon 5 and various NR1 mutations on proton inhibition. The coupling energy is the difference in free energy with respect to proton inhibition between the NR1-1 exon 5-containing mutant receptor and receptors containing wild-type NR1 ϩ exon 5 and mutant NR1 Ϫ exon 5. For our calculations we assume that the IC 50 values we measure approximate the K D for proton binding to a single site. We did not examine the coupling energy with respect to Zn 2ϩ because its IC 50 is decreased by the mutations to a point at which further reduction by exon 5 might not be fully detectable because of voltage-dependent channel block by high Zn 2ϩ concentrations. Figure 5 shows the indepen- Figure 6 . Effects of mutations in the N R1-1 M2 pore-forming region on proton inhibition and spermine relief of proton inhibition. A, Potentiation and block of NR1-1a/NR2B receptors by extracellular spermine (SP) is evident in the current-voltage relationship. B, E xchange of Asn 616 in NR1 for Arg relieves voltage-dependent channel block by spermine at hyperpolarized potentials (see Materials and Methods), but also attenuates spermine potentiation of receptor responses. C, Ratio of the current response obtained in the presence of 1 mM spermine to the control response recorded at fixed holding potentials illustrates more clearly both potentiation and block of wild-type N R1-1a / N R2B receptors by spermine (open squares, n ϭ 6 -8 oocytes at each holding potential). Filled squares show relief of voltage-dependent channel block by spermine and attenuation of spermine potentiation at pH 7.3 for mutant NR1 subunits (n ϭ 9 -11 oocytes at each holding potential). Identical results were found for 0.1 mM spermine (n ϭ 56, data not shown). D, Composite proton inhibition curves were constructed for wild-type N R1-1a / N R2B receptors (63 oocytes) and N R1-1a(N616R)/ N R2B (48 oocytes) receptors by normalizing current responses recorded at different pH values to those observed at pH 7.6 and expressing the mean response at each pH as a percent of the fitted maximum (see Materials and Methods) . N R1 N616R decreased the amount of tonic proton inhibition for receptors that both lack and contain exon 5 (data not shown; n ϭ 15 oocytes). E, Spermine potentiation, defined as the current recorded in the presence of 300 M spermine expressed as a percent of the control current response, is shown as a f unction of pH for N R1-exon 5/ N R2B receptors (data from 45 oocytes) and NR1-1a(N616R)/NR2B receptors (n ϭ 37). F, Plotting the degree of spermine potentiation against the degree of proton inhibition for the same data show that there is no apparent difference in the effect of spermine on wild-type and mutant receptors. Differences in spermine potentiation shown in panels C and E therefore result from the change in pH sensitivity shown in D. dent effects on proton inhibition of exon 5 and N R1-1 mutations (coexpressed with N R2B) within a pore-forming domain, at a potential site of disulfide linkage, and at an acidic residue. As a control for the reliability of this approach, we examined the mutations at two conserved extracellular cysteine residues (Cys 744 and C ys 798 in N R1-1a) that control a variety of important features of NMDA receptor f unction and may combine to form a disulfide bridge (Sullivan et al., 1994) . As expected, the coupling coefficient was less than that predicted for independent effects of amino acid substitutions at the two cysteine residues, consistent with the idea that the hypothesized disulfide linkage mediates the effects of these residues on the proton sensor. The predicted independence of the effects of exon 5 and mutations that alter the pH inhibition suggest that these perturbations in proton sensitivity are additive and thus occur by different mechanisms.
Polyamine relief of voltage-independent Zn 2؉ inhibition
Polyamines such as spermine have been shown to relieve tonic proton inhibition in a manner analogous to the effects of exon 5, suggesting that some extracellular modulatory systems (protons and spermine) previously considered to be independent actually work through convergent pathways (Traynelis et al., 1995) . To further examine the links between proton and Z n 2ϩ inhibition, we tested whether polyamines can mimic the effects of exon 5 on Zn 2ϩ inhibition in an manner analogous to the ability of polyamines to mimic exon 5-induced relief of proton inhibition. Because both Z n 2ϩ (see above) and polyamines can block the NMDA receptor pore, we coexpressed N R1-1a(N616R) and NR1-1b(N637R) with N R2B to minimize complications attributable to voltage-dependent effects of Z n 2ϩ (Mori et al., 1992; Kawajiri and Dingledine, 1993; Sakurada et al., 1993) and polyamines (Kashiwagi et al., 1997 ; see Materials and Methods).
Because polyamines can have both potentiating and inhibiting actions, we first performed experiments to ensure that these mutations, which abolished voltage-dependent polyamine block, did not abolish the ability of polyamines to relieve tonic proton inhibition and potentiate receptor function. Figure 6 A shows the voltage-dependent inhibition by polyamines as well as voltageindependent relief of proton block (i.e., polyamine potentiation). Figure 6 , B and C, confirms that replacement of the M2 asparagine with arginine removes voltage-dependent channel block by spermine (Kashiwagi et al., 1997) and also shows that potentiation of the current response by polyamines is reduced. Such a result could occur if the M2 mutation altered the ability of spermine to interact with the receptor, or if the pore mutations we used unexpectedly decreased the proton sensitivity. To distinguish between these two possibilities, we examined the proton sensitivity of NR1-1a(N616R)/NR2B receptors. The experiments described in Figure 6 D-F confirm that the M2 pore mutations decrease the proton sensitivity of the NMDA receptors and show that the level of decreased polyamine potentiation can be fully accounted for from the reduced proton sensitivity (i.e., less tonic inhibition to relieve means less potentiation by polyamines). These results suggest that the interaction between polyamines and receptors containing either NR1-1a or NR1-1a(N616R) subunits in combination with NR2B are similar. Kashiwagi et al. (1997) reported similar effects of pore mutations on pH inhibition while these experiments were in progress.
To test whether voltage-independent Zn 2ϩ inhibition, like proton inhibition, can be relieved by both exon 5 and polyamines, we constructed Zn 2ϩ inhibition curves in the absence and presence of 300 M spermine for NR1-1a(N616R)/NR2B and NR1-1b(N637R)/NR2B receptors. In the absence of exon 5, spermine caused an increase in the IC 50 for Zn 2ϩ inhibition from 4 to 24 Figure 7 . Relief of Zn 2ϩ inhibition by spermine. A, B, To test whether spermine also relieves voltageindependent Zn 2ϩ inhibition in an manner analogous to the effect of exon 5, Zn 2ϩ inhibition curves were constructed for exon 5-lacking N R1-1a(N616R)/ N R2B receptors in the absence and presence of 300 M spermine. This concentration of spermine induces no channel block of these mutant receptors (Fig. 5C) . Spermine shifted the IC 50 for Zn 2ϩ inhibition of receptor f unction by sixfold when exon 5 was absent ( A) and by 2.3-fold for receptors that contain exon 5 ( B). C, Top panel, Zn 2ϩ inhibition of glutamate-evoked NR1-1a(N616R)/ N R2B receptormediated currents recorded in either 10 or 100 M spermine at Ϫ30 mV. Calibration: 150 sec, 50 nA. Bottom panel, Spermine decreases the inhibition of N R1-1a(N616R)/ NR2B receptor responses observed in 10 M Zn 2ϩ in a dose-dependent manner with an IC 50 value of 90 M; spermine can similarly relieve the small amount of inhibition of exon 5-containing NR1-b(N637R)/NR2B receptors as well (open circles). D, To test whether the actions of spermine persist in the absence of polyamine potentiation, we evaluated the effect of spermine on Zn 2ϩ inhibition at pH 8.0 at which there is no spermine potentiation (i.e., because there is no inhibition by protons). Under these conditions, we still observe relief of Zn 2ϩ inhibition, consistent with the idea that spermine, like exon 5, can relieve Zn 2ϩ inhibition. Numbers in parentheses are the number of oocytes.
M ( Fig. 7A; a sixfold shift) . However, for N R1 subunits that contained exon 5, spermine had much more modest effects, shifting the Z n 2ϩ IC 50 value from 65 to 151 M ( Fig. 7B ; a 2.3-fold shift). These data suggest that spermine can increase the IC 50 value for Z n 2ϩ in an exon 5-dependent manner. If we assume that spermine -Z n 2ϩ binding (discussed below) only minimally influences free Z n 2ϩ concentration, then we can evaluate the concentration -effect relationship for spermine relief of Z n 2ϩ inhibition by examining the current response in the presence of 10 M Zn 2ϩ with or without a variable concentration of spermine present (Fig.  7C) . The result of this experiment suggests that spermine can relieve Z n 2ϩ inhibition almost completely with an EC 50 value of ϳ90 M (n ϭ 15) under these conditions.
Because spermine potentiates the NMDA receptors, any reduction by Z n 2ϩ of polyamine potentiation would reduce current response amplitude and thus, appear as an opposing effect to polyamine relief of Z n 2ϩ inhibition. That is, the current recorded in the presence of both spermine and Z n 2ϩ might be less than that recorded in spermine alone in part because of interference of spermine potentiation by Z n 2ϩ . This could cause an underestimation of the effects of spermine on Z n 2ϩ inhibition. To evaluate the effects of spermine on Z n 2ϩ inhibition without this confounding variable, we tested the effects of spermine on Z n 2ϩ inhibition at pH 8.0, a pH value at which there is almost no tonic proton inhibition, and thus, no polyamine potentiation (Fig. 7D) . Even in the absence of any potentiating actions of polyamines, we still see a relief of Z n 2ϩ inhibition by polyamines to approximately the same level reported at pH 7.3. Similar results to those shown in Figure 6 , C and D, were found when the above experiments were repeated with wild-type N R1-1/ N R2B receptors that lack or contain exon 5 (n ϭ 45 oocytes; data not shown).
The role of spermine-Zn(II) complexation in spermine relief of Zn 2؉ inhibition
Polyamines are known to chelate transition metals such as copper and zinc under certain conditions. For example, two spermine molecules can complex with Z n 2ϩ , and their interaction is stabilized at alkaline pH and by certain anions (Antonelli et al., 1984; Wojciechowska et al., 1991) . Accordingly, it is important to consider whether the effects of spermine we observe on voltageindependent Z n 2ϩ inhibition of NMDA receptor f unction simply reflect spermine binding of Z n 2ϩ . Although extensive data exists for Cu(II)-polyamine complexes as a f unction of pH, considerably less data exists for Z n(II)-polyamine complexes at different pH values. Although most Cu 2ϩ is complexed with spermine at physiological pH (Palmer and Powell, 1974; Wojciechowska et al., 1991) , Z n 2ϩ is known to form weaker complexes with polyamines (Antonelli et al., 1984; Wojciechowska et al., 1991) . For example, at pH 6, Ͻ2% of the Zn 2ϩ is complexed with spermine compared with 24% of Cu 2ϩ . Could the relief of Z n 2ϩ inhibition of NMDA receptor function by spermine that we observe be explained by spermine chelation of Z n 2ϩ ? T wo experimental observations make this unlikely. First, it is not possible to account for the different effects of spermine on receptors that lack and contain exon 5 by simply removing a fraction of the extracellular Z n 2ϩ from the solution. Second, spermine-transition metal complexes are pH-sensitive, with metal-spermine complexes being more prevalent at alkaline pH. However, we observe similar relief by spermine of Zn 2ϩ inhibition at pH 6.6, 7.3, and 8.0. Z n 2ϩ at 10 M inhibited NR1-exon 5(N616R)/ N R2B responses to 48 Ϯ 5% (pH 6.6; n ϭ 8), 47 Ϯ 3% (pH 7.3; n ϭ 6), and 48 Ϯ 4% (pH 8.0; n ϭ 11) of control, and this level of inhibition was reduced by 300 M spermine to 77 Ϯ 3% (pH 6.6), 76 Ϯ 3% (pH 7.3), and 75 Ϯ 2% (pH 8.0) of control ( p Ͼ 0.4 by ANOVA). Thus, if significant Zn 2ϩ -spermine complexation does occur at pH 7.3, our data suggest that either the complexed ion is biologically active or the spermine-water exchange rate of the complex is fast enough to allow Zn 2ϩ to rapidly interact with a binding site on the receptor protein.
Interactions between protons and Zn
2؉
Does Zn 2ϩ inhibition involve an enhancement of the proton sensitivity of the NMDA receptor such that tonic proton inhibition is enhanced in the presence of Zn 2ϩ ? Such a mechanism has been proposed to underlie inhibition of NMDA receptors by phenylethanolamines such as ifenprodil and its analogs (Mott et al., 1998) . We performed two experiments to evaluate the functional interaction between proton and Zn 2ϩ inhibition. First, we measured the Zn 2ϩ sensitivity of NMDA receptors at different pH values to assess whether alkaline pH relieved Zn 2ϩ inhibition. We found that that NR1-1a/NR2B receptors are similarly sensitive to extracellular Zn 2ϩ at both pH 8.0 (IC 50 , 2.2 M; n ϭ 10) and pH 6.6 (IC 50 , 3.0 M; n ϭ 10) pH values, compared with pH 7.3 (IC 50 , 2.5 M; Table 1 ). Modest effects of pH are expected because the ionization of residues that interact with Zn 2ϩ almost certainly will be affected by this pH change. However, the lack of a strong monotonic relationship between pH and Zn 2ϩ sensitivity is inconsistent with the idea that Zn 2ϩ inhibits receptor function by enhancement of pH sensitivity. Second, we tested whether extracellular Zn 2ϩ could alter proton sensitivity. Consistent with our idea that Zn 2ϩ inhibition does not reflect an enhancement of proton inhibition, we find no significant difference in proton inhibition at pH 6.6 or 6.8 in the absence or presence of 1 M extracellular Zn 2ϩ (n ϭ 19; p Ͼ 0.4; minimum detectable difference 17%). Zn 2ϩ appears to slightly enhance potentiation of current responses by pH 8.0 (122 Ϯ 6% of control; p Ͻ 0.05). Given the limited solubility of hydroxide-Zn(II) complexes that form at alkaline pH values (see Eq. 3, Materials and Methods), we might expect an enhanced current at pH 8.0 versus pH 7.3 if a small portion of the Zn 2ϩ precipitated slowly out of solution at pH 8.0. These data support the conclusion that Zn 2ϩ does not inhibit receptors by enhancing the pH sensitivity through a stabilization of the protonated state. Moreover, the data also show that NMDA receptor responses partially inhibited by protons are sensitive to Zn 2ϩ , and vice versa.
DISCUSSION
The two most important conclusions to emerge from this study are (1) that alternative splice variants of the NR1 subunit control voltage-independent inhibition by extracellular Zn 2ϩ and (2) that this form of Zn 2ϩ inhibition shares several prominent structural and functional features with proton inhibition. The effects of alternative exon splicing on Zn 2ϩ inhibition have interesting implications for the role of Zn 2ϩ in information processing. Postsynaptic neurons that contact presynaptic terminals that release Zn 2ϩ in a Ca 2ϩ -dependent manner might include NR1 exon 5 in the mature mRNA to either relieve tonic inhibition of postsynaptic receptor function by ambient levels of Zn 2ϩ in the extracellular space (Zheng et al., 1998) . On a structural level, the three parallels that we have described between protons and Zn 2ϩ inhibition (similar sensitivity to NR1 exon 5, polyamines, and NR1 mutations) suggest these two modulatory sites either contain overlapping structural components or converge on a common downstream mechanism.
Control of Zn
2؉ inhibition by alternative exon splicing NR1 exon 5 has widespread and interesting effects on NMDA receptor function (Durand et al., 1992 (Durand et al., , 1993 Sugihara et al., 1992; Hollmann et al., 1993) . Exon 5 is thought to encode an extracellular surface loop that may act as a tethered ligand that can influence several extracellular allosteric modulators, including protons and polyamines, as well as potentiation by Zn 2ϩ of NR1 subunits expressed without NR2 in Xenopus oocytes (Durand et al., 1992 (Durand et al., , 1993 Hollmann et al., 1993 , Westbrook, 1994 Traynelis et al., 1995) . Thus, the ability of exon 5 to influence voltageindependent inhibition by extracellular protons and Zn 2ϩ fits well with the idea that this portion of the protein may control access of extracellular ions to a complex regulatory site on the extracellular surface of the receptor. What ramifications does this altered sensitivity have for neurobiology? Exon 5 is expressed in a region-specific manner and regulated throughout development of the nervous system (Laurie and Seeburg, 1994; Nash et al., 1997; Paupard et al., 1997; Weiss et al., 1998) . Unfortunately, no data exist that allow a direct comparison of the relative abundance of NMDA receptors that lack and contain NR1 exon 5. However, it seems safe to suggest that in regions such as hippocampal CA3, in which exon 5 is expressed and Zn 2ϩ is released, that the presence of exon 5-containing NR1 subunits should decrease the response of the neurons to both ambient levels of Zn 2ϩ as well as synaptically released Zn 2ϩ .
Common functional and structural determinants of proton and Zn 2؉ inhibition
The idea that the structural determinants of proton and Zn 2ϩ binding might overlap was first suggested on the basis of the similarity between the pKa values of amino acid residues that frequently coordinate Zn 2ϩ and the IC 50 for proton inhibition of NMDA receptors (Peters et al., 1987; Westbrook and Mayer, 1987; Traynelis and Cull-Candy, 1990, 1991; Traynelis, 1998) . However, it is a particularly thorny issue to address with functional studies, given the proposed mechanism of action for protons. Traynelis and Cull-Candy (1991) have argued that a protonated NMDA receptor is nonfunctional, suggesting that the proton inhibition curve reflects an increasing fraction at any moment of receptors that remain only briefly protonated. If this view proves correct, it explains the additive rather than synergistic effects of proton and Zn 2ϩ inhibition. This is because a nonfunctional protonated receptor, regardless of whether it binds Zn 2ϩ , does not contribute to the current response. Thus the properties of residual currents at acidic pH should mirror properties of larger currents at alkaline pH because only unprotonated and thus fully functional receptors contribute to the response. Figure 8 . Structural models of proton and Z n 2ϩ action. A, If the proton sensor is a single ionizable amino acid residue ( X ) rather than carbohydrate or lipid, it could be physically distinct from the residues that bind Zn 2ϩ (R 1-3 ). At least three electron pairs are usually required to coordinate Zn 2ϩ ; fourth and /or fifth electron pairs could be provided by water or other amino acid residue(s) depending on coordination geometry. In this scenario, the acidic N R1 amino acid residues (D, E) studied in Figures 3 and 4 could enhance the manner by which both protons or Zn 2ϩ -binding influence channel gating, rather than altering the binding of either ion. Both exon 5 and polyamines are shown influencing the local microenvironment ( gray area) of each regulatory site, which could shift the pKa of the proton sensor and alter the association of Z n 2ϩ with its binding site. B, Although the proton sensor and Z n 2ϩ -binding site might be physically distinct, certain acidic residues alternatively could enhance the electronegativity and partial negative charge of the proton sensor and binding. E xon 5 and polyamines could influence the proton-and Zn 2ϩ -binding sites indirectly through association with these acidic residues, although this idea contradicts the additive effects of exon 5 and mutation E342Q in N R1. C, If a single amino acid residue constitutes the proton sensor, it might contribute to the Z n 2ϩ coordination site. This would transmit the effects of acidic residues that control the pKa of the proton sensor directly to the affinity of Z n 2ϩ for its binding site. Exon 5 and polyamines could, by shielding the proton sensor, directly influence Zn 2ϩ binding. Alternatively, exon 5 and polyamines might alter the pKa of the proton sensor by interacting with acidic residues that themselves influence the electronegativity of the proton sensor (but see Fig. 5 ).
There are several possible ways to explain our data describing parallel effects of spermine, exon 5, and selected N R1 residues on proton and Z n 2ϩ inhibition. Z n 2ϩ -binding to any protein reflects its coordination chemistry, which is flexible for Z n 2ϩ given its pseudonoble gas configuration (d 10 ). Z n 2ϩ is known to form tetrahedral, trigonal-bipyramid, square pyramid, octahedral, and other complexes in free solution (Huhey, 1983) , and additional geometries could be dictated by the structure and flexibility of the binding site within the protein. In other Z n 2ϩ -binding proteins, typically at least three electron pairs are provided by the protein to hybrid Z n 2ϩ orbitals (Frausto da Silva and Williams, 1991); water or additional amino acid residues may satisf y the other 1-3 coordination sites, depending on the coordination geometry. If we assume at least three electron donors exist that define the Zn 2ϩ -binding site on the NMDA receptor (Fig. 8) , we then must hypothesize that the neutralization of the partial or formal negative charge on these residues caused by Z n 2ϩ binding is sufficient to shut down receptor f unction. Alternatively, binding of Zn 2ϩ might decrease the degrees of freedom of one of the electron-donating groups and thus prevent the conformational changes necessary for channel opening.
At this juncture there are three different models that could explain our data. First, we could hypothesize that protons bind to a site separate from any of the electron donors to Z n 2ϩ ( Fig. 8 A) , and that binding of Z n 2ϩ or protons inhibits receptor f unction by controlling in a similar manner movement of the channel gate. This f unctional convergence could create the parallel effects we observe of nonexon 5 N R1 mutations on both proton and Zn 2ϩ effects, provided all of these mutations uncouple both Zn 2ϩ and proton binding from the downstream mechanisms. The effects of polyamines and exon 5 that we observe on proton and Zn 2ϩ inhibition are simplest to explain if both binding sites are close enough so that their local environments can be influenced by charged polyamines or residues near Lys 211 in exon 5. Second, the proton and Z n 2ϩ -binding sites could be separate but under the control of a handf ul of N R1 anionic residues (Glu 181 , Glu 342 , Asp 669 , etc.) that increase the partial negative charge on the proton sensor and are electron donors to Z n 2ϩ . In this scenario, the positive charges on exon 5 and polyamines could interact with these residues to reduce their effects on the proton and Zn 2ϩ -binding sites (Fig. 8 B) , although this idea is hard to reconcile with the additive effects of exon 5 and certain anionic residues (Fig. 5) . Third, the proton sensor could be a part of the Z n 2ϩ -binding site. In this scenario, similar effects on protein charge distribution and conformation might follow either Z n 2ϩ binding to its coordination site or protonation of a critical electron donor to Zn 2ϩ (Fig.  8C) . Both spermine and exon 5 could reduce the effectiveness of Zn 2ϩ and protons in this model by shielding the proton sensor to shift its pKa (Traynelis et al., 1995) , while at the same time altering the ionic microenvironment of the Z n 2ϩ -binding site and/or interfering with Z n 2ϩ access to the site. Alternatively, exon 5 and polyamines might interact with a variety of acidic residues that control the partial charge on the proton sensor (but see Fig. 5 ). An important part of this idea is that spermine and exon 5 must not associate so tightly with the proton sensorelectron donor so as to neutralize the partially or formally charged amino acid side chains, because such neutralization would inhibit the receptor (rather than relieve proton and Zn 2ϩ inhibition). This last model postulates three unique molecular interactions at the same binding site: protonation, coordination of a metal ion, and shielding.
Whereas identification of the proton sensor and residues that coordinate Zn 2ϩ would help in the evaluation of these models, efforts to find these sites using site-directed mutagenesis are likely to be fraught with interpretative difficulties. Removal of a residue that contributes, say, to Zn 2ϩ binding may cause only a shift in its IC 50 rather than abolish Zn 2ϩ binding if other nearby residues can also donate electron pairs, albeit less willingly. This reduces the search for Zn 2ϩ -binding partners to interpretation of partial shifts in the Zn 2ϩ sensitivity. Although construction of multiple mutations might pinpoint additional candidate residues that interact with Zn 2ϩ (Fig. 5) , the number of mutants to be investigated is substantial. Similarly, removal of the proton sensor by mutagenesis is likely to reveal other ionizable residues that can be protonated at higher acid concentrations and can alter receptor function. Again, the search for a key residue may well become an evaluation of subtle shifts in pH sensitivity. For these reasons, more complicated approaches probably will be needed to advance these structural models to the next level, such as biophysical analysis of the mechanisms of pH and Zn 2ϩ inhibition in concert with mutagenesis or perhaps biochemical cross-linking studies to identify residues that can associate with exon 5 in a polyaminesensitive manner.
Convergence of extracellular modulatory sites on the NMDA receptor
For nearly a decade the number of allosteric regulatory sites proposed to exist on the extracellular surface of the NMDA receptors has increased, and this hyperregulation has been taken as evidence of the importance of the receptor. The advent of molecular techniques, and in particular, site-directed mutagenesis, brought the first hints that many NMDA receptor modulators might share either portions of their binding sites or common downstream elements. Sullivan et al. (1994) showed that two extracellular cysteine residues control effects of redox modulators, protons, and polyamines. We provide data in this report (Fig. 7B ) further linking these two residues to voltageindependent Zn 2ϩ inhibition. Traynelis et al. (1995) showed that polyamine potentiation reflects the relief of tonic proton inhibition, a result that has been supported now by other investigators Kashiwagi et al., 1996) . Furthermore, Zheng et al. (1994) showed that potentiating actions of Zn 2ϩ on NR1 subunits expressed in Xenopus oocytes had structural parallels to polyamine potentiation [Traynelis et al. (1995) , see footnote 20]. Zheng et al. (1998) have recently shown that srcinduced potentiation of NMDA receptors likely reflects a shift in the Zn 2ϩ sensitivity. Thus, no less than five regulatory sites now appear linked in some way, and a similar convergence has become apparent among pore-blocking ions and drugs (Mori et al., 1992; Kawajiri and Dingledine, 1993; Sakurada et al., 1993) . Could this trend continue? Possibly so, because links between other regulatory compounds remain to be investigated (e.g., arachidonic acid, dynorphin, ethanol, neurosteroids, and pituitary adenylyl cyclaseactivating peptide; McBain and Mayer, 1994; Chen et al., 1995; Liu and Madsen, 1997; Wu and Dun, 1997; Engblom et al., 1997; Park-Chung et al., 1997) . Although it seems unlikely that all regulatory sites will end up sharing common structural elements, a prudent prediction would be that two or three classes of extracellular voltage-independent regulators will emerge. With clear links between Zn 2ϩ , pH, and polyamines, the stage has already been set for the discovery of molecules (e.g., ifenprodil; Kew et al., 1996; Mott et al., 1998 ) that regulate NMDA receptor function in a unique voltage-independent and noncompetitive manner through control of these modulatory sites. Such drugs at a mini-mum will be interesting research tools and may eventually lead to novel treatment of the multitude of neurological disorders that have been suggested to involve NMDA receptors.
